Literature DB >> 18210125

[Guidelines for ophthalmological screening of premature infants].

C Jandeck.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18210125     DOI: 10.1007/s00347-007-1674-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  19 in total

1.  [Comparison of the anatomical and functional outcome after laser or cryotherapy for retinopathy of prematurity (ROP)].

Authors:  C Jandeck; U Kellner; H Heimann; M H Foerster
Journal:  Ophthalmologe       Date:  2005-01       Impact factor: 1.059

Review 2.  The International Classification of Retinopathy of Prematurity revisited.

Authors: 
Journal:  Arch Ophthalmol       Date:  2005-07

3.  Screening examination of premature infants for retinopathy of prematurity.

Authors: 
Journal:  Pediatrics       Date:  2006-02       Impact factor: 7.124

4.  [Diode laser coagulation of stage 3+ retinopathy of prematurity].

Authors:  V Seiberth; O Linderkamp; I Vardarli; M C Knorz; H Liesenhoff
Journal:  Ophthalmologe       Date:  1996-04       Impact factor: 1.059

5.  The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years.

Authors:  William V Good
Journal:  Br J Ophthalmol       Date:  2006-08-16       Impact factor: 4.638

6.  An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity.

Authors: 
Journal:  Arch Ophthalmol       Date:  1987-07

7.  Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1988-04

8.  An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity.

Authors: 
Journal:  Arch Ophthalmol       Date:  1984-08

9.  A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome.

Authors:  Eugene Y J Ng; Brian P Connolly; J Arch McNamara; Carl D Regillo; James F Vander; William Tasman
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

10.  Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies.

Authors:  James D Reynolds; Velma Dobson; Graham E Quinn; Alistair R Fielder; Earl A Palmer; Richard A Saunders; Robert J Hardy; Dale L Phelps; John D Baker; Michael T Trese; David Schaffer; Betty Tung
Journal:  Arch Ophthalmol       Date:  2002-11
View more
  5 in total

1.  [Laser treatment or intravitreal VEGF inhibition for aggressive posterior retinopathy of prematurity?].

Authors:  T Barth; K Hufendiek; H Helbig; I Oberacher-Velten
Journal:  Ophthalmologe       Date:  2015-06       Impact factor: 1.059

2.  Macular morphology in former preterm and full-term infants aged 4 to 10 years.

Authors:  Achim Fieß; Johannes Janz; Alexander K Schuster; Ruth Kölb-Keerl; Markus Knuf; Bernd Kirchhof; Philipp S Muether; Jacqueline Bauer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-25       Impact factor: 3.117

3.  [Screening for retinopathy of prematurity: Trends over the past 5 years in two German university hospitals].

Authors:  P P Larsen; M-C Bründer; M Petrak; V Jehle; W A Lagrèze; F G Holz; A Stahl; T U Krohne
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

Review 4.  [Current ophthalmic aspects of acute retinopathy of prematurity].

Authors:  B Lorenz
Journal:  Ophthalmologe       Date:  2008-12       Impact factor: 1.059

5.  Prevalence and associated factors of strabismus in former preterm and full-term infants between 4 and 10 Years of age.

Authors:  Achim Fieß; Ruth Kölb-Keerl; Alexander K Schuster; Markus Knuf; Bernd Kirchhof; Philipp S Muether; Jacqueline Bauer
Journal:  BMC Ophthalmol       Date:  2017-12-02       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.